Laxmi Organic Industries Limited — PPTs, 20-05-2025: Investor Presentation

1. Financial Highlights:

Laxmi Organic reported consolidated revenue of INR 2,985 Cr for FY25, up 5%, while Q4 revenue fell 9% YoY to INR 782 Cr. EBITDA rose 9.4% to INR 280 Cr for the year, with margins expanding by 40 bps to 9.4%. Q4 EBITDA dropped 34% to INR 59 Cr due to one-time costs and a strong prior year quarter. Profit after tax declined 6% to INR 114 Cr for FY25 and fell 51% in Q4 to INR 22 Cr. Volume growth of 11% supported the year’s performance. Net debt stayed stable at about INR 500 Cr, with capital work-in-progress at INR 398 Cr supporting ongoing expansion.

2. Strategic Initiatives & Growth Drivers:

The company aims to double revenues and triple EBITDA by FY28 via capacity expansions, new launches, and wallet share gains. Brownfield expansion at Dahej and Lote involves INR 1100 Cr capex over FY25-28. A new Innovation Centre highlights increased R&D focus. Fluoro-intermediates production started, broadening the specialties portfolio. A Letter of Intent with Hitachi Energy targets eco-efficient gas technology, reinforcing sustainability and tech leadership.

3. Business Developments:

Commercial production at Lote fluorospecialties site began, diversifying revenues. Environmental clearances for Dahej keep greenfield projects on track. Technology integration from acquisitions (Miteni, Ketene/Diketene) enhances presence in specialty chemicals and ethyl acetate markets.

4. Market Position & Competitive Advantage:

Laxmi ranks as India’s market leader and among the top 3 globally (ex-China) in essentials, and top 5 in specialties. It benefits from cost leadership, scale, and robust R&D (~100 employees). Strong EHS and sustainability credentials reinforce its trusted and innovative market standing, with rapid technology scaling and customer focus distinguishing the company.

5. Investor Implications:

Strong potential for growth driven by capacity additions, product pipeline, and a diversified business model. Execution risks around fluorination scaling and capex timelines exist but are offset by prudent financial management. Key investor focus should be on volume and margin trends, plus progress at Dahej and Lote. Commitment to sustainability and innovation supports long-term value creation.